Efficacy and safety of antiplatelet drugs in patients with chronic kidney disease

The risks and benefits of antiplatelet treatment may be different in patients with chronic kidney disease, in whom tendency to thrombosis and bleeding hazards might be increased. Chronic kidney disease is also associated with poor response to antiplatelet therapy, and this represents a potentially i...

Full description

Saved in:
Bibliographic Details
Main Authors: İbrahim Yıldız (Author), Pınar Özmen Yıldız (Author), Oben Döven (Author)
Format: Book
Published: KARE Publishing, 2014-07-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!